Lupin Limited — Updates, 12-02-2025: Other Restructuring

Lupin Limited has announced a board meeting outcome where key decisions were made, including the reappointment of Ms. Vinita Gupta as CEO for five years from May 28, 2025, and Mr. Ramesh Swaminathan as Executive Director and CFO for five years starting March 26, 2025. The board approved the transfer of its Over-the-Counter (OTC) Consumer Healthcare Business to a yet-to-be-incorporated subsidiary, LupinLife Consumer Healthcare Limited, for an estimated consideration of ₹ 5,500 million to ₹ 6,500 million. Additionally, a new Employee Stock Option Scheme for 10 million shares was proposed, enhancing employee engagement and retention. This strategic repositioning may boost operational focus and growth in the consumer health sector, reflecting a positive outlook for investors.